0001541157 2026-07-02 2026-07-02 0001541157 1 2026-07-02 2026-07-02 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001541157 Akari Therapeutics Plc N/A N/A S-3 Akari Therapeutics Plc false Equity Ordinary Shares, $0.0001 par value per share true 479999920000 0.00012625 60599989.90 0.0001381 8368.86 60599989.90 8368.86 0.00 0.00 8368.86 Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement also covers such additional shares as may hereafter be offered or issued to prevent dilution resulting from stock splits, stock dividends, recapitalizations or certain other capital adjustments. Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended. The price per share and aggregate offering price are based on the average of the high and low prices of the Registrant's ADSs on June 30, 2026 as reported on the Nasdaq Capital Market, adjusted for ADS to ordinary share ratio.